Company or ticker...

Nurix Therapeutics

Nurix develops targeted protein modulation drugs for cancer and immune diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NRIX

2.7B

73.1

n/a

35.63%

Key Facts

M. Cap

PS

PE

YTD

2.7B

73.1

n/a

35.63%

10MA

20MA

50MA

200MA

$NRIX